Antonello C. Pinto
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Hemorrhagic pericardial cyst: prenatal ultrasound and magnetic resonance imaging with postnatal outcome and literature review.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: March 20, 2025
Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial.
Journal: American journal of hematology
Published: December 09, 2024
A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA.
Journal: Blood
Published: October 23, 2024
Metronomic chemotherapy and breast cancer: a critical evaluation of its role in the new landscape of therapeutics.
Journal: Expert opinion on drug safety
Published: October 18, 2024
Standard Versus Reduced CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: An Observational Multicenter Study.
Journal: Journal of clinical medicine
Published: October 08, 2024
Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study.
Journal: Cancers
Published: September 13, 2024
Synergizing Immunotherapy and Antibody-Drug Conjugates: New Horizons in Breast Cancer Therapy.
Journal: Pharmaceutics
Published: August 13, 2024
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Journal: HemaSphere
Published: May 19, 2022
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.
Journal: Hematological oncology
Published: May 16, 2022
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years.
Journal: Annals of hematology
Published: November 02, 2021
Last Updated: 09/26/2026